POET Technologies Faces a June Tightrope Between Shareholder Vote and Class-Action Deadline

POET Technologies heads into a critical June with shareholder vote on U.S. relocation, securities lawsuit deadline, and a $500M Lumilens supply deal that could offset its 45% stock crash.

The month of June is shaping up to be a binary event for POET Technologies, with two critical milestones arriving within days of each other. On June 26, shareholders will vote on relocating the company's headquarters to the United States — a move designed to shed the tax stigma that has kept many institutional investors on the sidelines. Just three days later, the window for lead plaintiffs to step forward in a securities class-action lawsuit closes on June 29. Sandwiched between these legal and corporate governance events is a strategic supply agreement with Lumilens that could eventually be worth half a billion dollars — enough to make the stock's recent 45% crash look like a distant memory if execution holds.

The Marvell Crisis That Triggered the Plunge

The cascade of trouble began in April when Marvell Semiconductor abruptly canceled all purchase orders with POET. The chip giant cited a breach of confidentiality after POET's chief financial officer, Thomas Mika, disclosed details about the business relationship with Marvell and Celestial AI during a public interview on April 21. The fallout was immediate and severe: on April 27, the stock collapsed by more than 45% intraday, wiping out months of gains in a single session.

That single event has since morphed into a legal headache. Three law firms — Rosen Law Firm, Faruqi & Faruqi, and Levi & Korsinsky — have filed class-action complaints on behalf of investors who bought POET shares between April 1 and April 27 of this year. Both CEO Suresh Venkatesan and CFO Mika are named as defendants. The deadline to apply as lead plaintiff is June 29, 2026, giving shareholders just a narrow window to organize.

The Lumilens Deal: A Billion-Dollar Bet on Photonics

Despite the legal cloud, POET has not been idle. In mid-May, the company inked a supply and development agreement with Lumilens focused on photonic wafer integration for AI networks. The initial purchase order is for $50 million worth of modules, but the contract includes an option to expand to more than $500 million over five years. The target applications are 800G and 1.6T connectors, as well as co-packaged optics — areas where bandwidth demand from hyperscalers is growing exponentially.

Engineering samples are expected by the end of 2026, with mass production slated for 2027. As part of the deal, Lumilens receives warrants to acquire up to roughly 22.9 million POET shares, of which about 2.3 million are immediately exercisable at a strike price of $8.25 per share over a nine-year term.

Cash in the Bank, But Losses Mounting

To fund the production ramp, POET has completed a $400 million capital raise. Management has said the money will go toward expanding wafer production and assembly capacity — with a target to scale up roughly tenfold by 2027 — as well as acquisitions and R&D. The company ended the most recent quarter with about $430 million in cash, providing a comfortable cushion.

Yet the financials tell a mixed story. First-quarter 2026 revenue came in at roughly $503,000, more than triple the year-earlier figure. But the net loss widened to $12.3 million, or $0.08 per share, compared with a profit of $0.08 per share in the year-ago period. POET also reported an accumulated deficit of $291 million and flagged a material weakness in internal controls.

The Shareholder Vote: Unlocking Institutional Demand

The June 26 vote on moving the corporate domicile to the U.S. is intended to eliminate POET's classification as a Passive Foreign Investment Company (PFIC) — a tax status that has discouraged American institutional investors from buying the stock. The board has already provided the necessary documentation for a Qualified Electing Fund election, and because POET expects a net loss for 2025, management believes no U.S. tax liability will arise from a timely election. Going forward, the company plans to publish annual PFIC status reports as a transparency gesture.

If the vote passes, the investor base could broaden significantly. But if it fails, the stock may continue to trade at a discount relative to peers.

Stock Price Volatility and Delivery Goals

After surging from $7 to above $20 in the wake of the Lumilens announcement, the shares have since retreated to around $12.20 — a decline of roughly 40% from the peak. The retreat reflects a combination of post-deal profit-taking, legal uncertainty, and lingering concerns over the Marvell fallout.

On the operational side, POET has set a target to ship over 30,000 optical engine modules in 2026. The company’s Malaysian facility is central to that effort, and the cash balance gives it room to ramp production without immediate financing pressure.

The next few weeks will clarify whether the legal and governance risks overshadow the technology story — or whether the Lumilens deal and the relocation vote can restore investor confidence. With the class-action clock ticking and the shareholder ballot box opening, all eyes are on POET's June deadline double-header.